Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator Therapy
Pfizer External Research & Grants (ER&G) (formerly Global Medical Grants & Partnerships) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s ER&G competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.
For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.
This competitive program invites interdisciplinary independent medical education proposals aimed at strengthening the competency of healthcare professionals involved in the management of adults with ulcerative colitis who are initiating S1Prm therapy.
Educational projects eligible for Pfizer support should integrate expertise from specialists (e.g., gastroenterology, cardiology, electrophysiology, S1Prm pharmacology, dermatology, ophthalmology, etc) to deliver comprehensive education on baseline assessments, especially ECG, outlined in the current U.S. Prescribing Information for S1Prm therapy.
PIRA™ proposals are AI generated and are not reviewed or endorsed by the sponsoring company.